| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2373757C Treatment of neurotic disorders |
| 12/31/2009 | US20090326249 Process for Preparation of Citalopram and Enantiomers |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326018 2-Phenyl indene derivatives useful as estrogen receptor ligands |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325919 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009157399A1 Sulfonamide compound or salt thereof |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | WO2009156889A1 Diaryl compounds and uses thereof |
| 12/30/2009 | WO2009156439A1 Process for the hydrogenolysis of furfuryl derivatives |
| 12/30/2009 | WO2009156336A1 Sulfoximinamide compounds for combating animal pests |
| 12/30/2009 | WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 12/30/2009 | EP2138487A1 Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders |
| 12/30/2009 | EP2137175A1 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome |
| 12/30/2009 | EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/30/2009 | EP1448567B1 Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
| 12/30/2009 | CN101616905A Benzofuran antiparasitic agents |
| 12/30/2009 | CN101613332A Method for separating solution rich in gulonic acid and vitamin C by ion exclusion chromatography |
| 12/30/2009 | CN101613331A Method for preparing 5-acetoxymethyl furfural with carbohydrate |
| 12/30/2009 | CN100575342C Substituted spirocyclic ketoenols |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 12/30/2009 | CA2728810A1 Process for the hydrogenolysis of furfuryl derivatives |
| 12/30/2009 | CA2728511A1 Sulfonamide compounds or salts thereof |
| 12/30/2009 | CA2727573A1 Diaryl compounds and uses thereof |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/30/2009 | CA2727078A1 Sulfoximinamide compounds for combating animal pests |
| 12/29/2009 | US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| 12/29/2009 | US7638642 Method for the preparation of D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638540 Benzofuran compound and medicinal composition containing the same |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | US7638457 preparation of a modified vanadium/phosphorus mixed oxide catalyst for the partial oxidation of n-butane to maleic anhydride; mainly vanadyl pyrophosphate and niobium as a promoter; improved activity; efficiency; optimal performance from beginning of catalytic lifetime |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2393183C Process for the preparation of 5-(1-piperazinyl)benzofuran-2-carboxamide by transition metal-catalysed amination |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2347763C Method of lithiating five-membered heterocycles |
| 12/24/2009 | US20090318715 Method for the Production of D,L-2-Hydroxy-4-Alkylthio Butyric Acid |
| 12/24/2009 | US20090318712 Catalyst system and method for producing carboxylic acids and/or carboxylic acid anhydrides |
| 12/24/2009 | US20090318703 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient |
| 12/24/2009 | US20090318693 Ligands for estrogen related receptors and methods for synthesis of said ligands |
| 12/24/2009 | US20090318548 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
| 12/24/2009 | US20090313889 Production of hydroxymethylfurfural |
| 12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
| 12/23/2009 | WO2009154780A1 S1p1 receptor agonists and use thereof |
| 12/23/2009 | WO2009154566A1 Production of hydroxymethylfurfural |
| 12/23/2009 | WO2009154207A1 Anthracene derivative and organic electroluminescent element using the same |
| 12/23/2009 | WO2009154041A1 Method for producing morphine |
| 12/23/2009 | EP2134683A2 Novel inhibitors hepatitis c virus replication |
| 12/23/2009 | EP1817309B1 Acetamide compounds as fungicides |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP1709037B1 Hiv protease inhibiting sulfonamides |
| 12/23/2009 | EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 12/23/2009 | CN101611008A Modulators of C3A receptor and methods of use thereof |
| 12/23/2009 | CN101610992A Alkylated heterocyclic reaction products useful as antioxidants |
| 12/23/2009 | CN101607951A Method for preparing escitalopram |
| 12/23/2009 | CN101607950A Method for preparing 5-amino benzofuran carboxylic ester |
| 12/23/2009 | CN101607949A Method for preparing 4-methyl-4-(2-methyl-3-furansulfenyl)-2-pentanone |
| 12/23/2009 | CN101607948A Method for preparing 4-methyl-4-(2-furanmethylthio)-2-pentanone |
| 12/23/2009 | CN100572372C Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 12/23/2009 | CN100572371C Trisubstituted furans suitable for the preparation of fragrance compositions |
| 12/23/2009 | CA2726126A1 Chemical transformation of lignocellulosic biomass into fuels and chemicals |
| 12/22/2009 | US7635781 Cyclopentadifuran derivatives; for preparation of catalyst components in the polymerization of olefins, particularly in the production of homo and copolymers of ethylene |
| 12/22/2009 | CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2453649C Process for the production of beraprost and its salts |
| 12/22/2009 | CA2445749C Dyeing agents for keratin fibers, containing n-heteroarylmethyl-m-phenylenediamine deritaves, as well as new n-heteroarylmethyl-m-phenylenediamine derivatives |
| 12/22/2009 | CA2430090C Improved synthesis of anhydroglycitol esters of improved colour |
| 12/22/2009 | CA2305803C Crystalline antifungal polymorph |
| 12/17/2009 | WO2009151299A2 Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof |
| 12/17/2009 | WO2009151061A1 Photoreactive composition, optical material, composition for forming holographic recording layer, holographic recording material, and holographic recording medium |
| 12/17/2009 | WO2009125938A3 Novel platensimycin derivatives, their intermediates, and process for prepararing the same, and new process for preparing platensimycin |
| 12/17/2009 | WO2009117498A3 Methods of making cyclododecatriene and methods of making laurolactone |
| 12/17/2009 | WO2009092590A3 2 -cyano phenyl sulfonamide derivatives useful as pesticides |
| 12/17/2009 | US20090312562 Catalyst Containing Titanium Dioxide, Particularly for the Production of Phthalic Anhydride |
| 12/17/2009 | US20090312352 Compositions and methods for treatment of disease caused by yersinia spp infection |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | CA2727226A1 Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof |
| 12/16/2009 | EP2133344A1 Method for continuously producing 2,5-dihydrofuran |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | CN101605320A Method and system for low-overhead mobility management protocol in internet protocol layer |
| 12/16/2009 | CN101602753A Ester compound in Neem oil as well as preparation method and application thereof |
| 12/16/2009 | CN101602752A N-sulfenamide group-N'-tert-butyl group-N and N'-diaryl hydrazide compound as well as preparation method and application thereof |
| 12/16/2009 | CN100569765C Citalopram intermediate crystal alkali |
| 12/16/2009 | CN100569764C Substituted benzamido methyl formate compound as well as preparation method and uses thereof |
| 12/16/2009 | CN100569734C Organic compound containing heteroatoms and its use in Zigler-Natta catalyst |
| 12/15/2009 | US7632861 1-Isobenzofuranethanamine, 1-[[[3,5-bis(trifluoromethyl)phenyl]methoxy]methyl]-1,3-dihydro-N,N-dimethyl-; use in treating a disorder associated with aberrant levels of tachykinins or serotonin; nerve system disorders |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632835 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide; potent openers of the KCNQ family of potassium ion channels; antiepileptic agents; anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 12/15/2009 | US7632790 Trisubstituted furans suitable for the preparation of fragrance compositions |
| 12/15/2009 | CA2555454C Mycophenolate mofetil impurity |
| 12/15/2009 | CA2525854C Acylsulfamide inhibitors of factor viia |
| 12/15/2009 | CA2482917C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 12/15/2009 | CA2399087C Use of retinoid-type compounds as antibacterial agents |
| 12/15/2009 | CA2209315C Gibberellins compounds for veterinary and medicinal applications |
| 12/10/2009 | WO2009148654A2 Cephalotaxus esters, methods of synthesis, and uses thereof |